A history of the term "DMARD"

被引:25
作者
Buer, Jonas Kure [1 ]
机构
[1] Univ Oslo, Dept Social Anthropol, N-0317 Oslo, Norway
关键词
DMARD; SAARD; RID; DC-ART; Drug classes; Rheumatology; History; Anthropology; ACTING ANTIRHEUMATIC DRUGS; REMISSION-INDUCING DRUGS; DISEASE-MODIFYING DRUGS; RHEUMATOID-ARTHRITIS; CLASSIFICATION; THERAPY; SAARDS; AZATHIOPRINE; COMBINATION;
D O I
10.1007/s10787-015-0232-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The article outlines a history of the concept of "disease-modifying antirheumatic drugs" or DMARDs-from the emergence in the 1970s of the idea of drugs with decisive long-term effects on bone erosion in rheumatoid arthritis (RA), through the consolidation and popularisation in the term DMARD in 1980s and 1990s. It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word. Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART). The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [31] Changes in physical activity measured by accelerometry following initiation of DMARD therapy in rheumatoid arthritis
    Prioreschi, Alessandra
    Hodkinson, Bridget
    Tikly, Mohammed
    McVeigh, Joanne A.
    RHEUMATOLOGY, 2014, 53 (05) : 923 - 926
  • [32] The likelihood of attaining and maintaining DMARD-free remission for various (rheumatoid) arthritis phenotypes
    Luurssen-Masurel, Nathalie
    van Mulligen, Elise
    Weel-Koenders, Angelique Elisabeth Adriana Maria
    Hazes, Johanna Maria Wilhelmina
    de Jong, Pascal Hendrik Pieter
    RHEUMATOLOGY, 2022, 61 (06) : 2275 - 2284
  • [33] Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study
    Saleem, Benazir
    Brown, Andrew K.
    Quinn, Mark
    Karim, Zunaid
    Hensor, Elizabeth M. A.
    Conaghan, Philip
    Peterfy, Charles
    Wakefield, Richard J.
    Emery, Paul
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (08) : 1316 - 1321
  • [34] Multimodal imaging of structural damage and inflammation in psoriatic arthritis: a comparison of DMARD-naive and DMARD-failure patients
    Renkli, Nagme O.
    Kleinrensink, Nienke J.
    Spierings, Julia
    Mastbergen, Simon
    Vonkeman, Harald E.
    Mooij, Shasti C.
    Schipper, Lydia G.
    Herman, Amin
    ten Katen, Iris
    Nap, Frank J.
    Hol, Marjolein E.
    de Jong, Pim A.
    Jansen, Mylene P.
    Foppen, Wouter
    RHEUMATOLOGY, 2024, : 1760 - 1769
  • [35] DMARD (disease-modifying antirheumatic drug) treatment in patients with former or current cancer
    Krueger, Klaus
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (03): : 206 - 211
  • [36] Sustained DMARD-free remission in rheumatoid arthritis - about concepts and moving towards practice
    Verstappen, Marloes
    JOINT BONE SPINE, 2022, 89 (06)
  • [37] Combination DMARD treatment with parenteral gold and methotrexate
    Rau, R
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S83 - S90
  • [38] Adherence to biologic DMARD therapies in rheumatoid arthritis
    Koncz, Tamas
    Pentek, Marta
    Brodszky, Valentin
    Ersek, Katalin
    Orlewska, Ewa
    Gulacsi, Laszlo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (09) : 1367 - 1378
  • [39] regThe patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study
    Verhoef, Lise M.
    Selten, Ellen M. H.
    Vriezekolk, Johanna E.
    de Jong, Alphons J. L.
    van den Hoogen, Frank H. J.
    den Broeder, Alfons A.
    Hulscher, Marlies E.
    RHEUMATOLOGY, 2018, 57 (11) : 1947 - 1955
  • [40] Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
    Burkard, Theresa
    Williams, Ross D.
    Vallejo-Yaguee, Enriqueta
    Huegle, Thomas
    Finckh, Axel
    Kyburz, Diego
    Burden, Andrea M.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (03)